More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
APHSA Economic Mobility & Well-Being Conference 2026
Work requirements are expanding and budgets are not. Let's build an employment program that meets you where you're at.
Spotlight On: Digital Solutions for Environment and Natural Resources
We combine topical expertise, environmental science, data analytics, & engineering to help agencies modernize systems & use data to support better decisions.
2026 Defense Health Information Technology Symposium (DHITS)
Readiness is a data problem. We have solutions. Book a demo of our defense health data tools and meet our military health team.
Abt Global Wins Seat on CMS RMADA 3 Contract Vehicle
Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3.